Spinal Cord Innovation in Pediatrics (SCiP)

History

2022: Neurostimulator announcement

In mid-November 2022, the medical technology company SpineX developed a non-invasive spinal cord neuromodulation technology designed to treat children with cerebral palsy Spinal Cord Innovation in Pediatrics.

Spinal Cord Innovation in Pediatrics (SCiP), using transcutaneous neurostimulation of the spinal cord, the technology is aimed at modulating dysfunctional connections between the brain and spinal cord.

Spinal cord neurostimulator released to treat children with cerebral palsy

In an experimental study, the company reported that 16 pediatric volunteer patients with varying degrees of cerebral palsy severity and different ages demonstrated improved sensorimotor function after treatment with the device. At the end of the 8-week study, the researchers reported that all children treated demonstrated improved sensorimotor function. During the study, children received two interventions a week, the developers said. These included activity-based neurorehabilitation therapy sessions during which children received neuromodulation procedures from the device.

Cerebral palsy is a group of movement disorders that usually occur due to damage to the developing brain, with symptoms affecting posture, gait, and balance. As of November 2022, there are no effective treatments for cerebral palsy. Some patients undergo invasive surgery in an attempt to address certain symptoms, such as spasticity, but there is a clear need for new effective treatments and less invasive alternatives.

SCiP technology can give an idea of ​ ​ methods of treating cerebral palsy, the device has been developed for use during physical rehabilitation sessions, SCiP is aimed at improving the connection between the brain and spinal cord to improve rehabilitation.^[1]

Notes